These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 1346626

  • 1. Involvement of dopamine D1 and D2 receptors in the regulation of proenkephalin mRNA abundance in the striatum and accumbens of the rat brain.
    Angulo JA.
    J Neurochem; 1992 Mar; 58(3):1104-9. PubMed ID: 1346626
    [Abstract] [Full Text] [Related]

  • 2. Irreversible blockade of D2 dopamine receptors by fluphenazine-N-mustard increases D2 dopamine receptor mRNA and proenkephalin mRNA and decreases D1 dopamine receptor mRNA and mu and delta opioid receptors in rat striatum.
    Chen JF, Aloyo VJ, Qin ZH, Weiss B.
    Neurochem Int; 1994 Oct; 25(4):355-66. PubMed ID: 7820070
    [Abstract] [Full Text] [Related]

  • 3. Dopaminergic regulation of striatal proenkephalin mRNA and prodynorphin mRNA: contrasting effects of D1 and D2 antagonists.
    Morris BJ, Höllt V, Herz A.
    Neuroscience; 1988 May; 25(2):525-32. PubMed ID: 3041310
    [Abstract] [Full Text] [Related]

  • 4. Regulation by dopaminergic neurotransmission of dopamine D2 mRNA and receptor levels in the striatum and nucleus accumbens of the rat.
    Angulo JA, Coirini H, Ledoux M, Schumacher M.
    Brain Res Mol Brain Res; 1991 Sep; 11(2):161-6. PubMed ID: 1661813
    [Abstract] [Full Text] [Related]

  • 5. Proenkephalin mRNA levels in rat striatum are increased and decreased, respectively, by selective D2 and D1 dopamine receptor antagonists.
    Morris BJ, Hunt SP.
    Neurosci Lett; 1991 Apr 29; 125(2):201-4. PubMed ID: 1831887
    [Abstract] [Full Text] [Related]

  • 6. Chronic treatment with pentazocine or SFK 10047 decrease proenkephalin mRNA levels in the rat striatum and nucleus accumbens.
    Angulo JA, Ledoux M, McEwen BS.
    Neurosci Lett; 1991 Jan 14; 122(1):47-9. PubMed ID: 1647506
    [Abstract] [Full Text] [Related]

  • 7. Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum.
    Chen JF, Aloyo VJ, Weiss B.
    Neuroscience; 1993 Jun 14; 54(3):669-80. PubMed ID: 8101360
    [Abstract] [Full Text] [Related]

  • 8. Effect of chronic typical and atypical neuroleptic treatment on proenkephalin mRNA levels in the striatum and nucleus accumbens of the rat.
    Angulo JA, Cadet JL, Woolley CS, Suber F, McEwen BS.
    J Neurochem; 1990 Jun 14; 54(6):1889-94. PubMed ID: 1971007
    [Abstract] [Full Text] [Related]

  • 9. Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: a double in situ hybridization study.
    Curran EJ, Watson SJ.
    J Comp Neurol; 1995 Oct 09; 361(1):57-76. PubMed ID: 8550882
    [Abstract] [Full Text] [Related]

  • 10. The effects of haloperidol on dopamine receptor gene expression.
    Fox CA, Mansour A, Watson SJ.
    Exp Neurol; 1994 Dec 09; 130(2):288-303. PubMed ID: 7867758
    [Abstract] [Full Text] [Related]

  • 11. Parallel decrease of glutamic acid decarboxylase and preproenkephalin mRNA in the rat striatum following chronic treatment with a dopaminergic D1 antagonist and D2 agonist.
    Caboche J, Vernier P, Julien JF, Rogard M, Mallet J, Besson MJ.
    J Neurochem; 1991 Feb 09; 56(2):428-35. PubMed ID: 1824860
    [Abstract] [Full Text] [Related]

  • 12. Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists.
    Morissette M, Grondin R, Goulet M, Bédard PJ, Di Paolo T.
    J Neurochem; 1999 Feb 09; 72(2):682-92. PubMed ID: 9930741
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. SCH 58261, a selective adenosine A2A receptor antagonist, decreases the haloperidol-enhanced proenkephalin mRNA expression in the rat striatum.
    Wardas J, Pietraszek M, Dziedzicka-Wasylewska M.
    Brain Res; 2003 Jul 11; 977(2):270-7. PubMed ID: 12834887
    [Abstract] [Full Text] [Related]

  • 19. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum.
    Aubert I, Ghorayeb I, Normand E, Bloch B.
    J Comp Neurol; 2000 Feb 28; 418(1):22-32. PubMed ID: 10701753
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.